Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...
(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...
Morning Overview on MSN
Living cells may generate electricity in a way we didn’t know
Electricity has always been central to how life works, from the firing of neurons to the beating of the heart, but new ...
Miracle Hill Thrift Store isn’t just a shopping destination—it’s a financial revolution disguised as rows of gently-used ...
From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...
There are "costs of life" that mechanical physics cannot calculate. A clear example is the energy required to keep specific ...
Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback